Skip to main content

Advertisement

SpringerLink
Log in

Using Polysorbates to Create Parenteral Dosage Forms of Hydrophobic Substances (A Review)

  • DRUG SYNTHESIS METHODS AND MANUFACTURING TECHNOLOGY
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Low solubility of drugs is a constantly encountered problem for pharmaceutical science in the field of parenteral dosage form development. This requires the active use of solubilizers to produce soluble forms of substances suitable for administration via injection and infusion. Polysorbates or Tweens are often used as surfactants with the same poly(oxyethylene) part and different fatty acids that form the corresponding esters to overcome the hydrophobic nature of drugs. The introduction of polysorbates into pharmaceutical science and practice still remains relevant due to their high solubilizing activity, compatibility with other surfactants and electrolytes, and insensitivity to pH changes. This review highlights the properties of polysorbates and their use in pharmaceutical development (for drugs used both in clinics and at various stages of research), which makes it possible to assess the prospects for using these excipients to create dosage forms with new hydrophobic active substances.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. A. N. Trefilova, E. R. Akhmarova, E. N. Pozyumko, et al., Vestn. VGU, Ser.: Khim., Biol. Farm., No. 3, 126 – 130 (2017).

  2. I. D. Gulyakin, L. L. Nikolaeva, E. V. Sanarova, et al., Razrab. Regist. Lek. Sredstv, 2(11), 96 – 112 (2015).

    Google Scholar 

  3. E. V. Sanarova, A. V. Lantsova, and N. A. Oborotova, Biofarm. Zh., 6(4), 3 – 13 (2014).

    Google Scholar 

  4. I. D. Gulyakin, L. L. Nikolaeva, N. A. Oborotova, et al., Razrab. Regist. Lek. Sredstv, 2(15), 52 – 59 (2016).

    Google Scholar 

  5. V. L. Bagirova, N. B. Demina, I. A. Devyatkina, et al., Farmateka, 6, 34 – 36 (1998).

    Google Scholar 

  6. R. C. Rowe, P. J. Sheskey, and M. E. Quinn, Handbook of Pharmaceutical Excipients, Pharmaceutical Press and American Pharmacists Association, London (2009), pp. 549 – 553.

    Google Scholar 

  7. H. Knoch, M. H. Ulbrich, J. J. Mittag, et al., Mol. Pharm., 18(8), 3147 – 3157 (2021).

    Article  CAS  Google Scholar 

  8. B. A. Kerwin, J. Pharm. Sci., 97(8), 2924 – 2935 (2008).

    Article  CAS  Google Scholar 

  9. S. Fekete, K. Ganzlera, and J. Fekete, J. Pharm. Biomed. Anal., 52(5), 672 – 679 (2010).

    Article  CAS  Google Scholar 

  10. A. D. Askretkov, P. M. Isaikina, S. A. Cherepushkin, et al., Razrab. Regist. Lek. Sredstv, 3(20), 124 – 129 (2017).

    Google Scholar 

  11. E. V. Blynskaya, S. V. Tishkov, K. V. Alekseev, et al., Farmatsiya, 66(1), 14 – 18 (2017).

    CAS  Google Scholar 

  12. E. V. Brovca, J. Mravljak, R. Sink, et al., Int. J. Pharm., 581, 119985, (2020).

    Google Scholar 

  13. M. A. Liebert, Int. J. Toxicol., 3(5), 1 – 82 (1984).

    Google Scholar 

  14. K. Wuchner, L. Yi, C. Chery, et al., J. Pharm. Sci., 111(5), 1280 – 1291 (2022).

    Article  CAS  Google Scholar 

  15. M. Agarkhed, C. O’Dell, M. C. Hsieh, et al., AAPS Pharm. Sci. Tech., 14(1), 1 – 9 (2013).

    Article  CAS  Google Scholar 

  16. F. Bensaid, C. Dagallier, J. R. Authelin, et al., Int. J. Pharm., 615(5), 121496 (2022).

    Article  CAS  Google Scholar 

  17. E. Ha, W. Wang, and Y. J. Wang, J. Pharm. Sci., 91(10), 2252 – 2264 (2002).

    Article  CAS  Google Scholar 

  18. M. T. Jones, H. C. Mahler, S. Yadav, et al., Pharm. Res., 35(8), 148 (2018).

    Article  Google Scholar 

  19. W. Kranz, K. Wuchner, E. Corradini, et al., J. Pharm. Sci., 109(10), 3064 – 3077 (2020).

    Article  CAS  Google Scholar 

  20. E. T. Maggio, J. Excipients Food Chem., 3(2), 45 – 53 (2012).

    CAS  Google Scholar 

  21. V. I. Grokhovskii, A. A. Bendryshev, S. V. Shvets, et al., Razrab. Regist. Lek. Sredstv, 2(19), 160 – 165 (2017).

    Google Scholar 

  22. J. L. Waters, O. E. P. Smith, W. Small, et al., J. Chromatogr. A, 1623, 461212 (2020).

    Article  CAS  Google Scholar 

  23. A. Sparreboom, M. Zhao, R. J. Brahmer, et al., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 773(2), 183 – 190 (2002).

    Article  CAS  Google Scholar 

  24. S. F. Zhang, D. Yan, H. Y. Tang, et al., Zhongyaocai (J. Chin. Med. Mater.), 32(6), 969 – 972 (2009).

  25. W. B. Shelley, N. Talanin, and E. D. Shelley, Lancet, 345(8960), 1312 – 1313 (1995).

    Article  CAS  Google Scholar 

  26. G. Cavaletti, E. Cavalletti, P. Montaguti, et al., NeuroToxicology, 18(1), 137 – 145 (1997).

    CAS  PubMed  Google Scholar 

  27. L. B. Michaud, V. Valero, and G. Hortobagyi, Drug Saf., 23(5), 401 – 428 (2000).

    Article  CAS  Google Scholar 

  28. Yu. N. Morozov, P. N. Kolotilov, V. P. Shabatin, et al., RU Pat. No. 2,440,120, Jan. 20, 2012.

  29. P. A. Cherepanov, RU Pat. No. 2,255,729, Jul. 10, 2005.

  30. V. P. Shabatin and P. S. Arsen’ev, RU Pat. Appl. No. 2007129916, Feb. 20, 2009.

  31. C.-S. Yong, B.-J. Park, D.-H. Kim, et al, Drug Dev. Ind. Pharm., 33(5), 531 – 534 (2007).

    Article  CAS  Google Scholar 

  32. H. Kaur, S. Ghosh, P. Kumar, et al., Life Sci., 2841, 1 – 11 (2021).

    Google Scholar 

  33. R. Xu, J. Wang, J. Xu, et al., Int. J. Nanomed., 15, 1149 – 1160 (2020).

    Article  CAS  Google Scholar 

  34. N. A. Wahgiman, N. Salim, M. B. A. Rahman, et al., Int. J. Nanomed., 14, 7323 – 7338 (2019).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, 24 Kashirskoe Shosse, Moscow, 115478, Russia

    E. V. Sanarova, A. V. Lantsova, L. L. Nikolaeva & N. A. Oborotova

Authors
  1. E. V. Sanarova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. V. Lantsova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. L. Nikolaeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. A. Oborotova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. V. Sanarova.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 56, No. 7, pp. 35 – 39, July, 2022.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sanarova, E.V., Lantsova, A.V., Nikolaeva, L.L. et al. Using Polysorbates to Create Parenteral Dosage Forms of Hydrophobic Substances (A Review). Pharm Chem J 56, 974–978 (2022). https://doi.org/10.1007/s11094-022-02735-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-022-02735-7

Keywords

Search

Navigation